AKT activation promotes resistance to standard chemotherapy and radiotherapy, whereas inhibition of AKT signaling induces apoptosis and decreased growth of tumor cells dependent on elevated AKT signaling for cell survival and growth. The gene discussed is AKT1; the disease is neoplasm.